ViiV Healthcare seeks EMA approval for HIV-1 drug candidate fostemsavir

This article was originally published here

Under the marketing authorisation application (MAA) submitted to the European Medicines Agency (EMA), the company has asked the regulator to review the potential use of fostemsavir in combination

The post ViiV Healthcare seeks EMA approval for HIV-1 drug candidate fostemsavir appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply